CynergisTek strengthens its service portfolio by partnering with GroupSense to provide enhanced and proactive cyber reconnaissance services and incident response services.
Austin, Texas & Arlington, Va. --CynergisTek (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, announces a new agreement with GroupSense to provide organizations with vital threat intelligence to identify and mitigate attacker activity. This partnership offers CynergisTek’s customer base ransomware negotiation services and provides increased capabilities around incident response (IR) training and tabletop exercises.
“In order for healthcare organizations to more successfully anticipate where cyber attackers are likely to be present, they need a clearer picture of their risk and a better understanding of their environment,” said Mac McMillan, President & CEO of CynergisTek. “Incorporating GroupSense’s capabilities into our Risk and Incident Response services enables us to assist our clients in performing better reconnaissance, thereby enhancing their resilience. Just as important as being able to anticipate the threat, so is being able to execute more precisely when adverse situations arise. Incorporating ransomware negotiation and deeper awareness into client IR immersive exercises and incident response further enhances the value of our support to our clients,” he says.
“I am excited about the launch of our partnership with CynergisTek,” said Kurtis Minder, founder and CEO of GroupSense. “Given the increased attack surface, especially in the healthcare industry, organizations need solutions, not an increase in alerts or data feeds. The combined digital risk and attack surface capability of GroupSense, with the solution expertise of CynergisTek, solves IT risk problems while reducing operational overhead.”
This partnership marks CynergisTek’s focus on building cyber resiliency by helping businesses become proactive against threats and develop effective incident response procedures. CynergisTek and GroupSense are providing customers with threat intelligence capabilities that allow for healthcare specific insight on where organizations should prioritize remediation efforts based on their specific risk profile. CynergisTek clients will have access to additional threat monitoring and foot printing capabilities that help expose unknown gaps that organizations may have with the use of GroupSense’s cyber reconnaissance platform and team of highly trained analysts.
GroupSense is a digital risk protection services company that delivers customer-specific intelligence that dramatically improves enterprise cybersecurity and fraud-management operations. Unlike generic cyber-intelligence vendors, GroupSense uses a combination of automated and human reconnaissance to create finished intelligence that maps to each customer's specific digital business footprint and risk profile. This enables customers and partners to immediately use GroupSense's intelligence to reduce enterprise risk, without requiring any additional processing or management by overstretched security and fraud-prevention teams. GroupSense is based in Arlington, Va., with a growing customer base that includes large enterprises, state and municipal governments, law enforcement agencies and more.
CynergisTek is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company's security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations.
Original Press Release: https://www.businesswire.com/news/home/20220316005363/en